About ConforMIS

“ We believe that optimising implant fit and performance requires a patient-specific approach. ”
No two knees are the same. No two ConforMIS knee implants are either.

 

Orthopaedics has historically been a game of averages. Average sizes. Average shapes. Average results. No more.

We start with a simple idea: make the implant fit the patient rather than force the patient to fit the implant

ConforMIS does something that we believe no other knee implant manufacturer has done. We put the patient at the centre of implant design. By combining advanced 3D imaging technology with the latest manufacturing capabilities, we customise each and every implant to the patient’s unique size and shape.

Our Company

We are a medical technology company that uses our proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, which we refer to as customised, to fit each patient’s unique anatomy. We believe we are the only company offering a broad line of patient-specific knee implants designed to restore the natural shape of a patient’s knee. In recent clinical studies, iTotal CR, our cruciate-retaining total knee replacement implant, demonstrated superior clinical outcomes, including better function and greater patient satisfaction compared to traditional, off-the-shelf implants.1,2,3

  • 2004
  • 2007
    Nov. 6, 2007: John Slamin, 30-year industry veteran, appointed Vice President of Implant Engineering
  • 2008
  • 2009
    Apr. 6, 2009: ConforMIS awarded a 2009 Medical Design Excellence Award (MDEA) for its minimally invasive, patient-specific iUni® and iDuo® partial knee implants
    Jun. 23, 2009: iDuo® receives CE Mark certification in all European Union markets
    Jul. 13, 2009: ConforMIS raises $50 million from private-equity and sovereign-wealth funds in the USA, Asia, Europe and the Middle East
    Dec. 14, 2009: iUni® G2 launched in the United States
  • 2010
    Apr. 13, 2010: iUni® G2 receives CE Mark certification in all European Union markets
    4 Nov, 2010: iDuo® G2 launched in United States
  • 2011
    Feb. 3, 2011: iTotal® CR receives 510(k) clearance from the United States Food and Drug Administration
    May 2011: first iTotal® cases
    Jun. 1, 2011: iTotal® CR receives CE Mark certification in all European Union markets
    Jun. 16, 2011: ConforMIS selected as winner for 2011 American Technology Award, recognising the iTotal® knee replacement system for outstanding achievement
  • 2012
    Jan. 30, 2012: ConforMIS raises $89 million Series E financing round
    May 25, 2012: ConforMIS iTotal® CR knee replacement system wins Silver in 2012 Medical Design Excellence Awards
    Oct. 3, 2012: iTotal® G2 launched in the United States and European Union
    Nov. 12, 2012: Peter Traynor, a 30-year industry veteran, appointed Chief Financial Officer
  • 2013
    May 16, 2013: Matthew Scott appointed Senior Vice President of Operations
    Aug. 2, 2013: ConforMIS expands its Series E financing to $167.7 million




1: Kurtz, et al; In Vivo Kinematics for Subjects Implanted With Either a Traditional or a Customized, Individually Made TKA. ICJR Pan Pacific 2014 Annual Meeting, Abstract # O21A2
2: Cates, et al; In Vivo Kinematics for Customized, Individually Made vs. Off-the-Shelf TKA During a Deep Knee Bend and Chair Rise. ICJR Pan Pacific 2014 Annual Meeting, Abstract # O11A2
3: Katthagen, et al; Comparison of Hospital Metrics and Patient Reported Outcomes for Patients with Customized, Individually Made Vs. Conventional TKA. World Arthroplasty Congress 2015